NEMERA

About NEMERA

As a world-leading drug device combination solutions specialist, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are the utmost holistic partner and help our customers succeed in the sprint to market. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Pharmapack Europe 2023

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
1 & 2 Feb 2023

Products from NEMERA (5)

  • Sof'Airless: mini airless system for small dose dermal applications

    Product Sof'Airless: mini airless system for small dose dermal applications

    Nemera offers high performance airless delivery systems for dermal and transdermal solutions, lotions and creams.

    Nemera’s airless systems, pumps and valves are designed to handle a variety of formulations with different viscosities.



    Sof’Airless XS is a protective min...
  • PUMPS SP27 / SP270+: quality and performance for ENT sprays

    Product PUMPS SP27 / SP270+: quality and performance for ENT sprays

    Nemera offers an extensive range of metered pumps and valves, compatible with a wide choice of actuators in different shapes and fitments for nasal, buccal and auricular delivery.
    Here our different pumps:
    SP27 - SP 37: Quality systems for unregulated markets

    SP270+ - SP370+: Quality...
  • Safe’n’Sound®: our passive safety device – Robust and ergonomic design for user safety

    Product Safe’n’Sound®: our passive safety device – Robust and ergonomic design for user safety

    Safe’n’Sound®: the safety device solution for small molecules and biologics
    Nemera leverages decades of manufacturing and development experience in parenteral complex devices moulding and assembly such as safety devices, pens, autoinjectors and implanters.

    Nemera’s Safe’n’Sound®...
  • Novelia®: Nemera’s preservative-free multidose eyedropper

    Product Novelia®: Nemera’s preservative-free multidose eyedropper

    Novelia®: Nemera’s preservative-free multidose eyedropper, is used across 4 continents
    Preservatives have been shown to be harmful to the eye and can lead patients to discontinue or skip treatment to avoid irritation and discomfort.
    The new preservative-free multidose ophthalmic packaging Novelia...
  • DPIs / PMDIs : expert in development & manufacturing of respiratory drug delivery devices

    Product DPIs / PMDIs : expert in development & manufacturing of respiratory drug delivery devices

    Nemera has a recognized expertise in the development and manufacturing of respiratory drug delivery devices, such as Dry Powder Inhalers (DPIs), pressurized Metered Dose Inhalers (pMDIs) and dose counters.

    More than ten million asthmatics rely everyday on devices manufactured by Nemera.

NEMERA Resources (2)

  • News Nemera: Stronger than ever

    More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.
  • Video Innovation in Connectivity Roundtable pt.1

    The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2